SCHEMBL7977830

SCHEMBL7977830

COC(=O)c1[nH]c2ncccc2c1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
KDM4E B2RXH2 3/20 0.59
GAA P10253 2/20 0.59
HTT P42858 2/20 0.59
NPSR1 Q6W5P4 1/20 0.59
PADI4 Q9UM07 1/20 0.59
MAP2K1 Q02750 1/20 0.54
AURKA O14965 1/20 0.42
PARP1 P09874 1/20 0.42
FEN1 P39748 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
HPGD P15428 1/20 0.41
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5761859 0.85 ALDH1A1 (0.60) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL7965829 0.84 MAP2K1 (0.54) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL7977591 0.83 MAP2K1 (0.52) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL16496843 0.83 MAP2K1 (0.52) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL1879902 0.83 MAP2K1 (0.52) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL28839540 0.83 MAP2K1 (0.52) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL16497485 0.82 AURKA (0.46) ALDH1A1KDM4ENPSR1MAP2K1AURKA
SCHEMBL16497245 0.82 MAP2K1 (0.51) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL7990805 0.81 MAP2K1 (0.50) ALDH1A1KDM4EGAAHTTNPSR1
SCHEMBL24483349 0.80 MAP2K1 (0.49) ALDH1A1KDM4EGAAHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110312938-A1 Pyrrolopyridine Carboxylic Acid Derivatives IRONWOOD PHARMACEUTICALS, INC. (US) 2011-12-22 US disclosed
US-20110312938-A1 Pyrrolopyridine Carboxylic Acid Derivatives IRONWOOD PHARMACEUTICALS, INC. (US) 2011-12-22 US disclosed
US-20110312938-A1 Pyrrolopyridine Carboxylic Acid Derivatives IRONWOOD PHARMACEUTICALS, INC. (US) 2011-12-22 US disclosed
WO-2010005528-A2 PYRROLOPYRIDINE CARBOXYLIC ACID DERIVATIVES IRONWOOD PHARMACEUTICALS INCORPORATED (US) 2010-01-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312938-A1 Pyrrolopyridine Carboxylic Acid Derivatives SDHA, ALDH5A1, SDHB ALDH1A1 50/4885KDM4E 3282/4885GAA 283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.